ASIASTRATEGY (SORA) Fundamental Analysis & Valuation

NASDAQ:SORA • KYG8946B1086

Current stock price

2.3506 USD
+0.1 (+4.47%)
Last:

This SORA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SORA Profitability Analysis

1.1 Basic Checks

  • In the past year SORA has reported negative net income.
  • SORA had a negative operating cash flow in the past year.
SORA Yearly Net Income VS EBIT VS OCF VS FCFSORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

  • SORA has a Return On Assets of -4.25%. This is in the lower half of the industry: SORA underperforms 69.57% of its industry peers.
  • SORA has a Return On Equity of -6.78%. This is in the lower half of the industry: SORA underperforms 69.57% of its industry peers.
Industry RankSector Rank
ROA -4.25%
ROE -6.78%
ROIC N/A
ROA(3y)1.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SORA Yearly ROA, ROE, ROICSORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • SORA's Gross Margin of 7.23% is on the low side compared to the rest of the industry. SORA is outperformed by 69.57% of its industry peers.
  • The Profit Margin and Operating Margin are not available for SORA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SORA Yearly Profit, Operating, Gross MarginsSORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 2 4 6 8

6

2. SORA Health Analysis

2.1 Basic Checks

  • SORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SORA remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, SORA has an improved debt to assets ratio.
SORA Yearly Shares OutstandingSORA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
SORA Yearly Total Debt VS Total AssetsSORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • SORA has an Altman-Z score of 8.60. This indicates that SORA is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.60, SORA belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
  • SORA has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.34, SORA is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 8.6
ROIC/WACCN/A
WACC8.47%
SORA Yearly LT Debt VS Equity VS FCFSORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M 3M

2.3 Liquidity

  • SORA has a Current Ratio of 5.85. This indicates that SORA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of SORA (5.85) is better than 91.30% of its industry peers.
  • A Quick Ratio of 4.39 indicates that SORA has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 4.39, SORA belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.85
Quick Ratio 4.39
SORA Yearly Current Assets VS Current LiabilitesSORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

0

3. SORA Growth Analysis

3.1 Past

  • SORA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2755.56%.
  • Looking at the last year, SORA shows a very negative growth in Revenue. The Revenue has decreased by -17.70% in the last year.
EPS 1Y (TTM)-2755.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.73%
Revenue 1Y (TTM)-17.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-44.64%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SORA Yearly Revenue VS EstimatesSORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M

0

4. SORA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SORA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SORA Price Earnings VS Forward Price EarningsSORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SORA Per share dataSORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. SORA Dividend Analysis

5.1 Amount

  • No dividends for SORA!.
Industry RankSector Rank
Dividend Yield 0%

SORA Fundamentals: All Metrics, Ratios and Statistics

ASIASTRATEGY

NASDAQ:SORA (4/21/2026, 1:24:53 PM)

2.3506

+0.1 (+4.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap58.44M
Revenue(TTM)22.01M
Net Income(TTM)-605.40K
AnalystsN/A
Price TargetN/A
Short Float %0.26%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.66
P/FCF N/A
P/OCF N/A
P/B 6.54
P/tB 6.54
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.89
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -6.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.23%
FCFM N/A
ROA(3y)1.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.85
Quick Ratio 4.39
Altman-Z 8.6
F-Score3
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2755.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-44.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-172.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-134.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-134.05%
OCF growth 3YN/A
OCF growth 5YN/A

ASIASTRATEGY / SORA Fundamental Analysis FAQ

What is the fundamental rating for SORA stock?

ChartMill assigns a fundamental rating of 2 / 10 to SORA.


What is the valuation status of ASIASTRATEGY (SORA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ASIASTRATEGY (SORA). This can be considered as Overvalued.


Can you provide the profitability details for ASIASTRATEGY?

ASIASTRATEGY (SORA) has a profitability rating of 0 / 10.